Thrombosis News

 
 
  • ESOC 2023 Preventive Antipyretics, Antibiotics Not Needed in Stroke Prophylactic use of antiemetic, antipyretic, or antibiotic drugs in older patients with acute stroke did not reduce the risk of a poor functional outcome in the PRECIOUS trial.
  • ESOC 2023 Intensive BP Reduction After Stroke Recanalization Harmful Intensive blood pressure management worsens outcomes and should not be pursued in stroke patients successfully recanalized with intra-arterial thrombectomy, results of the OPTIMAL-BP trial show.
  • Troponin to ID Diabetes Patients With Silent Heart Disease? US adults with type 2 diabetes and asymptomatic for cardiovascular disease had twice the prevalence of an elevated level of cardiac troponin T compared with those without diabetes.
  • ESOC 2023 Tenecteplase Late After Stroke Misses Endpoint: TIMELESS Giving very late thrombolysis to patients with large-vessel occlusion small core strokes did not show a significant benefit in the TIMELESS trial, although there were some encouraging findings.
  • Ticagrelor, DAPT Equal in Preventing Repeat Revascularization After percutaneous coronary intervention, ticagrelor alone or with aspirin are equally effective in preventing repeat revascularization at one year in a post-hoc TWILIGHT analysis.
  • EuroPCR 2023 ECMO Signal of Benefit for Cardiogenic Shock After MI Though based on small numbers in a halted trial, ECMO was associated with reduced mortality for PCI patients in MI-related cardiogenic shock, results of the EURO SHOCK trial suggest.
  • ESOC 2023 Cardiopathy No Basis for Choosing Anticoagulation in ESUS Clinicians shouldn't expect apixaban to offer benefit over aspirin in patients with embolic stroke of undetermined source simply because they have atrial cardiopathy, ARCADIA investigators conclude.
  • ESOC 2023 No Added Benefit From Revascularization in Low-Risk CAS Optimized medical therapy may be enough in patients with carotid artery stenosis who have a low to intermediate stroke risk, after the ESCT-2 trial showed no benefit from adding revascularization.
  • HRS 2023 Leadless Dual-Chamber Pacemaker Clears Performance Hurdles It's actually two leadless pacemakers, one atrial and the other ventricular, linked as if in a wireless network, that together maintained true AV synchronous pacing in a short-term study.
  • Real-World Data Validate ESC Risk Model in NSTE-ACS A real-world study has potentially validated a risk model put forward by the European Society of Cardiology for management of acute coronary syndromes without persistent ST-segment elevation.
  • ESOC 2023 Earlier Anticoagulation Safe in Stroke With AF: ELAN Patients presenting with ischemic stroke found to have atrial fibrillation can safely start a direct oral anticoagulant much earlier than starting occurs in current practice, a new study suggests.
  • Marijuana Linked to Higher PAD Risk A large study found marijuana users had almost four times the risk of peripheral artery disease, but no higher risk of death or coronary intervention.
  • SPARTAN 2023 TNF, JAK Inhibitors' CV Safety Compared in PsA, AxSpA JAK inhibitors were not associated with higher risk of myocardial infarction or stroke and venous thromboembolism, compared with TNF-inhibitor users, in a small study.
  • Age-Specific Cut-Offs Needed for Cardiac Troponin Tests? Using age-specific thresholds for troponin measurement would more accurately diagnose myocardial injury when assessing patients for suspected MI, a new study suggests.
  • EuroPCR 2023 Evidence of TAVR Benefit Extends to Cardiogenic Shock Patients in cardiogenic shock should not be excluded from transcatheter aortic valve replacement, despite some early adverse event risk, new registry data suggest.
  • EHRA 2023 Surprisingly More NSVT Using Extended ECG Monitoring in HCM With implications for sudden-death risk assessment, 30-day compared to 24-hour monitoring may detect far more clinically important arrhythmias in patients with hypertrophic cardiomyopathy.
  • AHA Flags Differing CVD Risk in Asian American Subgroups Examining Asian American subgroups separately is 'crucial' to understanding distinctions among them and how these differences affect their risk of type 2 diabetes and CVD, a new AHA statement says.
  • High Follistatin Predicts Poor Cardiometabolic Outcomes Elevated plasma levels of the liver protein follistatin may predict incident chronic kidney disease and other adverse outcomes, independent of diabetes, based on 23-year follow-up of a Swedish cohort.
  • AAN 2023 Stroke Scale Cutoff Might Not Be Ideal Guide 'When you are discussing when to perform CTA in patients with a low NIHSS score, you are discussing the majority of patients,' said Dr Theresa Sevilis regional medical director for TeleSpecialists.
  • First In Utero Cerebrovascular Surgery Success In a first-of-its-kind in utero surgery, researchers have successfully repaired a vein of Galen malformation, which often leads to heart failure, severe brain injury, or possibly death soon after birth.